Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors

Details for Australian Patent Application No. 2004283854 (hide)

Owner Actelion Pharmaceuticals Ltd

Inventors Fischli, Walter; Remen, Lubos; Bezencon, Olivier; Richard-Bildstein, Sylvia; Bur, Daniel; Weller, Thomas; Sifferlen, Thierry

Agent A J Park

Pub. Number AU-A-2004283854

PCT Pub. Number WO2005/040173

Priority PCT/EP03/11740 23.10.03 EP

Filing date 18 October 2004

Wipo publication date 6 May 2005

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/040173 Priority application(s): WO2005/040173

25 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283869-Device for storing and dispensing a flowable substance

2004283853-Human chemokine HCC-1 polypeptides to improve stem cell transplantation